Market Overview - The Hong Kong stock market experienced a decline, with the Hang Seng Index falling by 0.71% to close at 25,635.23 points, the Hang Seng Tech Index down by 0.3% at 5,483.01 points, and the China Enterprises Index decreasing by 0.26% to 8,891.71 points [1] - Major technology stocks mostly declined, with Alibaba down 1.85%, Tencent Holdings down 1.08%, and JD Group down 0.71%. However, Netease and Meituan saw gains of 1.41% and 0.97%, respectively [1] - Gold stocks fell significantly, with WanGuo Gold Group dropping over 6% and several others declining more than 5% [1] - Robotics stocks led the market, with MicroPort Robotics-B rising over 25% and UBTECH increasing by over 9% [1] - Automotive stocks performed well, with NIO up over 4% and both Xpeng Motors and BYD close to 4% [1] - Gaming stocks generally fell, with MGM China dropping over 17%, while Chinese brokerage stocks also saw declines, with China International Capital Corporation down over 2% [1] Company News - Kuaishou-W (01024.HK) repurchased 464,000 shares for approximately HKD 29.99 million at prices between HKD 64.05 and HKD 64.90 [2] - Bank of China (03988.HK) completed the issuance of HKD 50 billion in tier-2 capital bonds to supplement its tier-2 capital [2] - Weisheng Holdings (03393.HK) entered into a capital increase agreement with Boyu Capital, raising RMB 380 million for new shares [2] - Green Leaf Pharmaceutical (02186.HK) granted exclusive commercialization rights for three long-acting injectable antipsychotic products to Enhua in mainland China [3] - Hengrui Medicine (01276.HK) had its SHR-A1904 injection included in the list of breakthrough therapy products by the drug review center [4] - Tencent Holdings (00700.HK) repurchased 1.056 million shares for approximately HKD 636 million at prices between HKD 598 and HKD 604 [6] - COSCO Shipping Holdings (01919.HK) repurchased 1.96 million shares for approximately HKD 27.23 million at prices between HKD 13.82 and HKD 13.95 [7] - Xiaomi Group-W (01810.HK) repurchased 3.8 million shares for approximately HKD 149 million at prices between HKD 39.08 and HKD 39.26 [8] - Youzhiyou Biotechnology-B (02496.HK) received IND approval from NMPA for Y225 (Aimeisai monoclonal antibody injection) [9] - MicroPort Robotics-B (02252.HK) achieved a global commercialization milestone with over 100 installations of its surgical robots [10] - China Huadian Corporation (01071.HK) completed the construction and operation of two 660,000 kW ultra-supercritical units at the Huadian Longkou Phase IV project [11] - Energy International Investment (00353.HK) plans to issue a total of 1.035 billion shares at an approximately 18.33% discount, raising about HKD 254 million [12] Institutional Insights - CITIC Securities forecasts that the Hong Kong stock market may experience a second round of valuation recovery and performance revival in 2026, driven by internal and external economic factors [13] - Huatai Securities notes that the market is still in a left-side layout phase, with supply and demand pressures expected to persist towards the end of the year [14] - Qianhai Kaiyuan Fund's chief economist Yang Delong predicts that the Hong Kong stock market will regain upward momentum in 2026, driven by capital inflows and a potential long-term bull market [15]